支气管扩张症患者气道高反应性干预对肺功能及临床疗效的影响  

Influence of treatment airway hyperreactivity on lung function and clinic effect in individuals with bronchiectasis

作　　者：吴友茹[1] 陈明勇[1] 袁晓玲[1] 张金蓉[1] 

机构地区：[1]绵阳市中心医院呼吸内科,四川绵阳621000

出　　处：《四川医学》2013年第1期59-61,共3页Sichuan Medical Journal

摘　　要：目的探讨支气管扩张症患者气道高反应性干预对肺功能及临床疗效的影响。方法选择诊断支气管扩张症合并气道高反应性患者186例随机分成治疗干预组和对照组各93例,治疗干预组用药物干预其气道高反应性,对照组常规治疗。检测肺功能变化和临床疗效。结果治疗组肺功能指标FEV1,FEF25%,FEF50%,FEF75%和气道高反应均较对照组明显改善,发病次数亦明显减少,差异有统计学意义。结论支气管扩张伴气道高反应性患者药物干预可以保护患者肺功能、减少支气管扩张的急性发病次数。Objective To observe the clinic effect of treatment airway hyperreactivity on lung function and clinic effect in individuals with bronchiectasis. Methods 186 individuals with bronchiectasis and airway hyperreactivity were randomly divided into two groups; group 1 （R = 93 ） were treated with medicine for airway hyperreactivity, and group 2 （n = 93 ） with route medi- cine. The function of lung and clinic effect were detected after 6months. Results Lung function and airway hyperreactivity of indi- vidual of the treated group were improved contrast with other group,The rate of acute aggression in individual of the treated group has induced, the difference between two groups has significance. Conclusion Airway hyperreactivity in patients with bronchiecta- sis was treated with medicine can protect lung function and reduce the incidence of acute aggression.

关 键 词：支气管扩张症 气道高反应性 肺功能 临床疗效 

分 类 号：R562.22[医药卫生—呼吸系统]